Influence of chitosan nanoparticles as the absorption enhancers on salvianolic acid B in vitro and in vivo evaluation

Pharmacognosy Magazine

Volumn 12, Issue 45, 2016, Pages 57-63

  Jin, Xin ^a   Zhang, Shi Bing ^a   Li, Shi Meng ^a   Liang, Ke ^b   Jia, Zeng Yong ^a  

^a Suqian First Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Absorption enhancer; bioavailability; Caco 2 cell model; chitosan; chitosan nanoparticles; molecular weight; salvianolic acid B

Indexed keywords

CHITOSAN NANOPARTICLE; SALVIANOLIC ACID B;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CACO 2 CELL LINE; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR WEIGHT; MTT ASSAY; NONHUMAN; RAT; SALVIA MILTIORRHIZA; SCANNING ELECTRON MICROSCOPY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ZETA POTENTIAL;

EID: 84958959218     PISSN: 09731296     EISSN: 09764062     Source Type: Journal    
DOI: 10.4103/0973-1296.176047     Document Type: Article

References (32)

1. Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345-59.
2. Kamata K, Iizuka T, Nagai M, Kasuya Y. Endothelium-dependent vasodilator effects of the extract from Salviae miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. Gen Pharmacol 1993;24:977-81.
3. Kamata K, Noguchi M, Nagai M. Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae radix in the rat. Gen Pharmacol 1994;25:69-73.
4. Tang MK, Ren DC, Zhang JT, Du GH. Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 2002;9:405-9.
5. Schipper NG, Vârum KM, Stenberg P, Ocklind G, Lennernäs H, Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs 3: Influence of mucus on absorption enhancement. Eur J Pharm Sci 1999;8:335-43.
6. Zhou L, Chow MS, Zuo Z. Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B. Int J Pharm 2009;379:109-18.
7. Zhou W, Zhu XX, Yin AL, Cai BC, Wang HD, Di L, et al. Effect of various absorption enhancers based on tight junctions on the intestinal absorption of forsythoside A in Shuang-Huang-Lian, application to its antivirus activity. Pharmacogn Mag 2014;10:9-17.
8. Barakat NS, Almurshedi AS. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: In-vitro/in-vivo evaluation. J Pharm Pharmacol 2011;63:169-78.
9. Prego C, Fabre M, Torres D, Alonso MJ. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm Res 2006;23:549-56.
10. Pan Y, Li YJ, Zhao HY, Zheng JM, Xu H, Wei G, et al. Bioadhesive polysaccharide in protein delivery system: Chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002;249:139-47.
11. Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J Pharm Pharmacol 2009;61:1609-16.
12. Tan ML, Choong PF, Dass CR. Cancer, chitosan nanoparticles and catalytic nucleic acids. J Pharm Pharmacol 2009;61:3-12.
13. Chen Y, Zhao YH, Jia XB, Hu M. Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo). Pharm Res 2008;25:2190-9.
14. Tanaka Y, Taki Y, Sakane T, Nadai T, Sezaki H, Yamashita S. Characterization of drug transport through tight-junctional pathway in Caco-2 monolayer: Comparison with isolated rat jejunum and colon. Pharm Res 1995;12:523-8.
15. Yan HM, Zhang ZH, Jiang YR, Ding DM, Sun E, Jia XB. An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188. Pharmacogn Mag 2014;10 Suppl 2:S311-7.
16. Turco L, Catone T, Caloni F, Di Consiglio E, Testai E, Stammati A. Caco-2/TC7 cell line characterization for intestinal absorption: How reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human? Toxicol In vitro 2011;25:13-20.
17. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanopraticles as protein carrier. J Appl Polym Sci 1997;63:125-32.
18. Jin X, Zhang ZH, Sun E, Tan XB, Zhu FX, Jia XB. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: In vivo and in vivo evaluations. Drug Dev Ind Pharm 2013;39:1421-30.
19. Jin X, Zhang ZH, Sun E, Tan XB, Li SL, Cheng XD, et al. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: In vitro and in vivo studies. Int J Nanomedicine 2013;8:641-52.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
21. Chae SY, Jang MK, Nah JW. Influence of molecular weight on oral absorption of water soluble chitosans. J Control Release 2005;102:383-94.
22. Jin X, Zhang ZH, Sun E, Qian Q, Tan XB, Jia XB. Preparation of a nanoscale baohuoside I-phospholipid complex and determination of its absorption: In vivo and in vitro evaluations. Int J Nanomedicine 2012;7:4907-16.
23. Jin X. A nanostructured liquid crystalline formulation of 20(S)-protopanaxadiol with improved oral absorption. Fitoterapia 2013;84:64-71.
24. Guan M, Zhu QL, Liu Y, Bei YY, Gu ZL, Zhang XN, et al. Uptake and transport of a novel anticancer drug-delivery system: Lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers. Int J Nanomedicine 2012;7:1921-30.
25. Dudhani AR, BioaKosaraju S.L. Bioadhesive chitosan nanoparticles: Preparation and characterization. Carbohydr Polym 2010;81:243-51.
26. Lin YH, Chen CT, Liang HF, Kulkarni AR, Lee PW, Chen CH, et al. Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nano-technology 2007;18:105102.
27. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 2010;62:3-11.
28. Lian H, Sun J, Yu YP, Liu YH, Cao W, Wang YJ, et al. Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery. Int J Nanomedicine 2011;6:3323-34.
29. Zhou W, Qin KM, Shan JJ, Ju WZ, Liu SJ, Cai BC, et al. Improvement of intestinal absorption of forsythoside A in Weeping forsythia extract by various absorption enhancers based on tight junctions. Phytomedicine 2012;20:47-58.
30. Li YH, Zhang M, Wang JC, Zhang S, Liu JR, Zhang Q. Effects of absorption enhancers on intestinal absorption of lumbrokinase. Yao Xue Xue Bao 2006;41:939-44.
31. Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine 2011;6:765-74.
32. Zhang HL, Zhong XB, Tao Y, Wu SH, Su ZQ. Effects of chitosan and water-soluble chitosan micro-and nanoparticles in obese rats fed a high-fat diet. Int J Nanomedicine 2012;7:4069-76.